Matches in SemOpenAlex for { <https://semopenalex.org/work/W2060295864> ?p ?o ?g. }
- W2060295864 endingPage "105" @default.
- W2060295864 startingPage "100" @default.
- W2060295864 abstract "Existing prognostic algorithms for localized prostate cancer (PC) are hampered by poor validation for endpoints other than biochemical relapse such as clinical disease progression or survival. Therefore, the prognostic relevance of Her-2 (Her-2/neu, c-erbB2) protein expression in patients undergoing curative radiotherapy (RT) was compared to widely accepted prognostic factors such as pretreatment prostate-specific antigen (PSA) levels, biopsy Gleason score and T category of the primary tumor. Biopsies from 112 homogeneously treated patients with T1-4pN0M0 PC were examined by immunohistochemistry and 37% of cases showed membrane-bound Her-2 expression in more than 10% of cancer cells. No definite membrane staining was seen in normal prostate epithelium. With 25 patients dead of PC and a median follow-up of surviving patients of 71 months (range 48-144), the prognostic relevance of Her-2 expression was univariately associated with adverse outcome in terms of biochemical or clinical progression-free survival (B/C-PFS; p = 0.04), clinical progression-free survival (C-PFS; p = 0.02) and disease-specific survival (DSS; p = 0.02). In multivariate analysis, Her-2 expression, T category and Gleason score were independently associated with C-PFS, whereas only Her-2 expression and Gleason score were associated with DSS. Her-2 expression and Gleason score together discriminated 2 groups of patients with 5-year DSS of 95% and 79%, respectively (p < 0.001). Pretreatment PSA levels were associated only with B/C-PFS but not with C-PFS or DSS. Together the data show for the first time that expression of Her-2 is of prognostic relevance in localized PC undergoing RT and suggest that analysis for Her-2 may improve prognostic algorithms for clinically relevant endpoints other than biochemical relapse." @default.
- W2060295864 created "2016-06-24" @default.
- W2060295864 creator A5000813742 @default.
- W2060295864 creator A5003293427 @default.
- W2060295864 creator A5008004523 @default.
- W2060295864 creator A5044514299 @default.
- W2060295864 creator A5055817555 @default.
- W2060295864 creator A5062805582 @default.
- W2060295864 date "2002-02-25" @default.
- W2060295864 modified "2023-10-12" @default.
- W2060295864 title "Independent prognostic significance of HER-2 oncoprotein expression in pN0 prostate cancer undergoing curative radiotherapy" @default.
- W2060295864 cites W1580523172 @default.
- W2060295864 cites W1820106848 @default.
- W2060295864 cites W188996788 @default.
- W2060295864 cites W1911051620 @default.
- W2060295864 cites W1976381106 @default.
- W2060295864 cites W1990208211 @default.
- W2060295864 cites W1996646886 @default.
- W2060295864 cites W2001184843 @default.
- W2060295864 cites W2014538286 @default.
- W2060295864 cites W2028000100 @default.
- W2060295864 cites W2043009773 @default.
- W2060295864 cites W2043353211 @default.
- W2060295864 cites W2068776651 @default.
- W2060295864 cites W2071704431 @default.
- W2060295864 cites W2072068836 @default.
- W2060295864 cites W2077778212 @default.
- W2060295864 cites W2084591997 @default.
- W2060295864 cites W2094455666 @default.
- W2060295864 cites W2105829250 @default.
- W2060295864 cites W2108199169 @default.
- W2060295864 cites W2110488527 @default.
- W2060295864 cites W2115047638 @default.
- W2060295864 cites W2117570501 @default.
- W2060295864 cites W2127268764 @default.
- W2060295864 cites W2144866895 @default.
- W2060295864 cites W2248001437 @default.
- W2060295864 cites W2324490223 @default.
- W2060295864 cites W4294715705 @default.
- W2060295864 cites W4300944403 @default.
- W2060295864 cites W45711525 @default.
- W2060295864 cites W51158438 @default.
- W2060295864 doi "https://doi.org/10.1002/ijc.10286" @default.
- W2060295864 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11948499" @default.
- W2060295864 hasPublicationYear "2002" @default.
- W2060295864 type Work @default.
- W2060295864 sameAs 2060295864 @default.
- W2060295864 citedByCount "47" @default.
- W2060295864 countsByYear W20602958642012 @default.
- W2060295864 countsByYear W20602958642015 @default.
- W2060295864 countsByYear W20602958642017 @default.
- W2060295864 countsByYear W20602958642021 @default.
- W2060295864 crossrefType "journal-article" @default.
- W2060295864 hasAuthorship W2060295864A5000813742 @default.
- W2060295864 hasAuthorship W2060295864A5003293427 @default.
- W2060295864 hasAuthorship W2060295864A5008004523 @default.
- W2060295864 hasAuthorship W2060295864A5044514299 @default.
- W2060295864 hasAuthorship W2060295864A5055817555 @default.
- W2060295864 hasAuthorship W2060295864A5062805582 @default.
- W2060295864 hasConcept C10515644 @default.
- W2060295864 hasConcept C121608353 @default.
- W2060295864 hasConcept C126322002 @default.
- W2060295864 hasConcept C142724271 @default.
- W2060295864 hasConcept C143998085 @default.
- W2060295864 hasConcept C204232928 @default.
- W2060295864 hasConcept C2775934546 @default.
- W2060295864 hasConcept C2776235491 @default.
- W2060295864 hasConcept C2777008409 @default.
- W2060295864 hasConcept C2779466945 @default.
- W2060295864 hasConcept C2780192828 @default.
- W2060295864 hasConcept C2780739268 @default.
- W2060295864 hasConcept C2781197716 @default.
- W2060295864 hasConcept C3019894029 @default.
- W2060295864 hasConcept C509974204 @default.
- W2060295864 hasConcept C55493867 @default.
- W2060295864 hasConcept C63363279 @default.
- W2060295864 hasConcept C71924100 @default.
- W2060295864 hasConcept C86803240 @default.
- W2060295864 hasConceptScore W2060295864C10515644 @default.
- W2060295864 hasConceptScore W2060295864C121608353 @default.
- W2060295864 hasConceptScore W2060295864C126322002 @default.
- W2060295864 hasConceptScore W2060295864C142724271 @default.
- W2060295864 hasConceptScore W2060295864C143998085 @default.
- W2060295864 hasConceptScore W2060295864C204232928 @default.
- W2060295864 hasConceptScore W2060295864C2775934546 @default.
- W2060295864 hasConceptScore W2060295864C2776235491 @default.
- W2060295864 hasConceptScore W2060295864C2777008409 @default.
- W2060295864 hasConceptScore W2060295864C2779466945 @default.
- W2060295864 hasConceptScore W2060295864C2780192828 @default.
- W2060295864 hasConceptScore W2060295864C2780739268 @default.
- W2060295864 hasConceptScore W2060295864C2781197716 @default.
- W2060295864 hasConceptScore W2060295864C3019894029 @default.
- W2060295864 hasConceptScore W2060295864C509974204 @default.
- W2060295864 hasConceptScore W2060295864C55493867 @default.
- W2060295864 hasConceptScore W2060295864C63363279 @default.
- W2060295864 hasConceptScore W2060295864C71924100 @default.
- W2060295864 hasConceptScore W2060295864C86803240 @default.
- W2060295864 hasIssue "1" @default.